Rare diseases
Investigational molecules
Locations
364 conditions with trials, the busiest first
1 201 trials across Europe, recruiting first
Study on Long-Term Safety of Cendakimab for Adults and Adolescents with Eosinophilic Esophagitis
Austria
BelgiumStudy of benralizumab compared to placebo for treatment of patients with Hypereosinophilic Syndrome (HES)
AustriaStudy on the Effectiveness and Safety of Barzolvolimab in Adults with Active Eosinophilic Esophagitis
GermanyStudy of RVU120 for Patients with Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
FranceA Phase 2 Study of JNJ-79635322 in Patients with Relapsed or Refractory Multiple Myeloma
ItalyPhase 1b Study of MK-0482 in Adults with Relapsed or Refractory Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia
SpainEvaluation of the Efficacy, Safety, and Tolerability of Subcutaneous REGN7999 in Adults with Iron Overload Due to Non-Transfusion Dependent Beta-Thalassemia
GreeceA study evaluating glofitamab and a drug combination for patients with relapsed or refractory diffuse large B-cell lymphoma.
BelgiumPharmacokinetic, Safety, and Efficacy Evaluation of ASTX727 and Venetoclax in Adult Patients with Acute Myeloid Leukemia
SpainMultiple Ascending Dose Safety, Tolerability and Pharmacokinetics of MK-7602 in Healthy Volunteers for Malaria
BelgiumPhase II Study of ME-401, Rituximab and Bendamustine as First‑Line Treatment for High‑Risk and Low‑Risk Follicular Lymphoma Patients
SwedenThe therapies tested most often in Blood and lymphatic system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
